Olympus Stem Cells Pty Ltd are pleased to announce the provision of medical services relating to the use of Stem Cells for facial rejuvenation. Full details are available through http://www.olympusstemcells.com.au.
The Medical Director of Olympus Stem Cells, Associate Professor Russell Vickers, has published extensively on the use of stem cells in facial and nerve anomalies. He has also conducted ground breaking research and patented the use of Zinc Thymulin for hair regeneration and he has published an article about this in The Journal of Hair Therapy and Transplantation in 2017. He is now undertaking clinical treatment of patients desiring aesthetic facial rejuvenation in both males and females.
He explains: "Stem Cells are extracted from abdominal wall fat following a mini liposuction procedure. The procedure is conducted under local anaesthesia and stem cells extracted following aspiration of 20-40cc's of fat. The cells and stromal vascular fraction are then injected into the face, neck, orbit and associated wrinkles."
As shown on http://www.olympushealthgroup.com.au, Olympus Stem Cells Pty Ltd undertake this ground breaking treatment in Australia and the Asia-Pacific region. They also announced that the surgery is day stay only. Associate Professor Vickers recent research publications pertaining to stem cells can be found in the AUSTRALIAN ENDODONTIC JOURNAL (2018), by NE Braunsteiner, ER Vickers, et al., Psychosocial factors and addiction in chronic orofacial pain, HAIR THERAPY AND TRANSPLANTATION (2017), by ER Vickers, An Analysis of the Safety and Efficacy of Topical Zinc-Thymulin to treat Androgenetic Alopecia, DIAGNOSING DENTAL AND OROFACIAL PAIN (2017), by ER Vickers, AJ Moule, Diagnosing neuropathic orofacial pain. A Clinical Manual, JOURNAL OF THE AUSTRALIAN SOCIETY OF COSMETIC CHEMISTS (2016), by ER Vickers, The Science of Beauty. Stem Cells and cosmetic science, MEDICINE TODAY (JOURNAL OF THE ROYAL AUSTRALIAN COLLEGE OF GENERAL PRACTITIONERS) (2015), by ER Vickers, Neuropathic orofacial pain: Diagnosis and multimodal management, and JOURNAL OF PAIN RESEARCH (2014), by ER Vickers, Karsten E, Flood J, Lilischkis R., A preliminary report on stem cell therapy for neuropathic pain in humans.
Further information about the research work completed by Associate Professor Vickers through Olympus Stem Cells Pty Ltd are available on the Clinical Stem Cells website at http://www.clinicalstemcells.com.
Olympus Stem Cells Pty Ltd are a clinical research and development biotech company engaged in stem cell therapy in Sydney, Australia.
Olympus Stem Cell Centre,
Sydney Olympic Park,
5 Australia Avenue,
Sydney Olympic Park,
NSW, Australia.
April 12, 2018 – Olympus Stem Cells Pty Ltd Australia Demonstrating Superior Stem Cell Numbers and Viability in Treatment for Neuropathy
April 12, 2018 – Stem Cells For Hair Regeneration
April 04, 2018 – Dry Mouth from Sjogren’s Syndrome or Head and Neck Radiation: Olympus Stem Cells Advise Technical Considerations in Surgery
April 03, 2018 – Dry Eyes and Stem Cells: Olympus Stem Cells Advise Technical Considerations in Surgery
April 02, 2018 – Olympus Stem Cells Using Zinc Thymulin, Micro-Fat Grafting and Stem Cells for Baldness
April 02, 2018 – Olympus Stem Cells Using Palmitoylethanolamide (PEA) and Stem Cells for Control of Disabling Facial Neuropathic Pain
March 26, 2018 – Olympus Stem Cells Pty Ltd Highlight Relationship Between Goblet Cells, Neuropathic Pain and Post LASIK Dry Eye Syndrome
March 26, 2018 – Olympus Stem Cells Pty Ltd Highlight Relationship Between Neural Crest Cells and Neuropathic Pain in Empty Nose Syndrome
